Bosutinib: Transforming the therapeutic landscape for HER2-positive and triple-negative breast cancer. // Innovative Practice in Breast Health. – URL: https://www.sciencedirect.com/science/article/pii/S2950212825000089?dgcid=rss_sd_all
Bosutinib: Transforming the therapeutic landscape for HER2-positive and triple-negative breast cancer. Innovative Practice in Breast Health. https://www.sciencedirect.com/science/article/pii/S2950212825000089?dgcid=rss_sd_all
“Bosutinib: Transforming the therapeutic landscape for HER2-positive and triple-negative breast cancer.” Innovative Practice in Breast Health.
@article{article49088,
title = {Bosutinib: Transforming the therapeutic landscape for HER2-positive and triple-negative breast cancer},
journal = {Innovative Practice in Breast Health},
url = {https://www.sciencedirect.com/science/article/pii/S2950212825000089?dgcid=rss_sd_all}
}